Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines.

Saved in:
Bibliographic Details
Title: Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines.
Authors: Khushman M; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Patel GK; Department of Oncologic Sciences, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Hosein PJ; Medical Oncology, The University of Miami, Sylvester Cancer Center, Miami, Florida, USA., Laurini JA; Department of Pathology, The University of South Alabama, Mobile, Alabama, USA., Cameron D; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Clarkson DR; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Butler TW; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Norden CW; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Baliem W; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Jones V; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Bhadkamkar S; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Nelson C; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Lee F; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Singh AP; Department of Oncologic Sciences, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA., Taylor WR; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, Alabama, USA.
Source: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2018 Jun; Vol. 9 (3), pp. 416-424.
Publication Type: Journal Article
Journal Info: Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2078-6891
DOI:10.21037/jgo.2018.02.03